title: A comprehensive analysis of predicted HLA binding peptides of JE viral proteins specific to north Indian isolates.
abstract: Japanese encephalitis (JE), a viral disease has significantly increased worldwide especially, in the developing region due to challenges in immunization, vector control and lack of appropriate treatment methods. An effective, yet an expensive heat-killed vaccine is available for the disease. Therefore, the design and development of short peptide vaccine candidate is promising. We used immune-informatics methods to perform a comprehensive analysis of the entire JEV proteome of north Indian isolate to identify the conserved peptides binding known specific HLA alleles among the documented JEV genotypes 1, 2, 3, 4 and 5. The prediction analysis identified 102 class I (using propred I) and 118 class II (using propred) binding peptides at 4% threshold value. These predicted HLA allele binding peptides were further analyzed for potential conserved region using IEDB (an immune epitope database and analysis resource). This analysis shows that 78.81% of class II (in genotype 2) and 76.47% of HLA I (in genotype 3) bound peptides are conserved. The peptides IPIVSVASL, KGAQRLAAL, LAVFLICVL and FRTLFGGMS, VFLICVLTV, are top ranking with potential super antigenic property by binding to all HLA allele members of B7 and DR4 super-types, respectively. This data finds application in the design and development of short peptide vaccine candidates and diagnostic agents for JE following adequate validation and verification.
authors.affiliation: School of Biotechnology, IFTM University, Lodhipur Rajput, Delhi Road (NH-24), Moradabad, 244001, U.P., India ; Institute of Biomedical Education and Research, Mangalayatan University, Aligarh, 202145, India.
authors.forename: Pawan
authors.initials: P
authors.lastname: Sharma
authors.affiliation: Institute of Biomedical Education and Research, Mangalayatan University, Aligarh, 202145, India.
authors.forename: Komal
authors.initials: K
authors.lastname: Saxena
authors.affiliation: School of Biotechnology, IFTM University, Lodhipur Rajput, Delhi Road (NH-24), Moradabad, 244001, U.P., India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Mishra
authors.affiliation: Institute of Biomedical Education and Research, Mangalayatan University, Aligarh, 202145, India.
authors.forename: Ajay
authors.initials: A
authors.lastname: Kumar
keywords: Immunoinformatics; epitope; short peptide; supertype; vaccine
references.citation: Front Biosci. 2005 Jan 01;10:879-86
references.pmid: 15569626
references.citation: Bioinformatics. 2001 Dec;17(12):1236-7
references.pmid: 11751237
references.citation: Curr Top Microbiol Immunol. 2002;267:105-38
references.pmid: 12082985
references.citation: J Gen Virol. 1995 Feb;76 ( Pt 2):401-7
references.pmid: 7844559
references.citation: Cell Immunol. 2006 Dec;244(2):141-7
references.pmid: 17434154
references.citation: Uirusu. 2005 Dec;55(2):303-6
references.pmid: 16557017
references.citation: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004263
references.pmid: 17636750
references.citation: Am J Trop Med Hyg. 1995 Sep;53(3):278-83
references.pmid: 7573713
references.citation: Southeast Asian J Trop Med Public Health. 1974 Dec;5(4):560-8
references.pmid: 4376275
references.citation: Science. 2013 May 10;340(6133):711-6
references.pmid: 23539181
references.citation: Immunogenetics. 2011 Jun;63(6):325-35
references.pmid: 21305276
references.citation: Emerg Infect Dis. 2006 Sep;12(9):1427-30
references.pmid: 17073095
references.citation: Am J Trop Med Hyg. 2001 Sep;65(3):242-51
references.pmid: 11561712
references.citation: Indian J Med Res. 1993 Jan;97:9-13
references.pmid: 8387460
references.citation: Microbiol Immunol. 1995;39(4):269-73
references.pmid: 7651240
references.citation: J Gen Virol. 2000 Oct;81(Pt 10):2471-2480
references.pmid: 10993935
references.citation: Bioinformatics. 2003 May 22;19(8):1009-14
references.pmid: 12761064
references.citation: Clin Infect Dis. 2012 Sep;55(6):825-34
references.pmid: 22696017
references.citation: Biologicals. 1997 Mar;25(1):27-34
references.pmid: 9167006
references.citation: Am J Trop Med Hyg. 1992 Jul;47(1):61-9
references.pmid: 1322071
references.citation: Curr Top Microbiol Immunol. 2002;267:171-94
references.pmid: 12082989
references.citation: Immunol Cell Biol. 2002 Jun;80(3):255-69
references.pmid: 12067413
references.citation: Vaccine. 2013 Dec 17;32(1):119-23
references.pmid: 24176496
references.citation: PLoS One. 2013 Apr 23;8(4):e61135
references.pmid: 23637790
references.citation: Curr Top Microbiol Immunol. 2002;267:11-48
references.pmid: 12082986
references.citation: J Infect Dis. 1992 Apr;165(4):631-7
references.pmid: 1313068
references.citation: Nucleic Acids Res. 2005 Oct 27;33(19):e166
references.pmid: 16257977
references.citation: Curr Top Microbiol Immunol. 2002;267:139-52
references.pmid: 12082987
references.citation: Clin Infect Dis. 2002 Jul 15;35(2):183-8
references.pmid: 12087525
references.citation: Arch Virol. 2003 Aug;148(8):1569-91
references.pmid: 12898332
references.citation: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W138-42
references.pmid: 15980443
references.citation: J Gen Virol. 1990 Dec;71 ( Pt 12):2915-22
references.pmid: 2273391